Finally, we investigated whether, and how, intestinal Leap2 expression is altered in mouse models of obesity/type 2 diabetes and how such alterations relate to those of the eCBome in the same models, where profound gut microbiota perturbations, sometimes referred to as dysbiosis, also exist. This evidence concerns the gene LEAP2 and obesity due to melanocortin 4 receptor deficiency.